New drug combo could shrink skin tumors before surgery
NCT ID NCT06418724
First seen Mar 31, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study tests whether giving two drugs (a PD-1 inhibitor and an EGFR inhibitor) before surgery can shrink advanced skin cancer tumors enough to make surgery easier or even unnecessary. About 27 adults with borderline resectable skin cancer will receive up to 4 cycles of these drugs. The goal is to see if the combination is safe and effective at reducing the cancer before any operation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.